HUP9801219A2 - Triciklusos N-acilezett benzazepin és benzoxazepinszármazékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra - Google Patents
Triciklusos N-acilezett benzazepin és benzoxazepinszármazékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukraInfo
- Publication number
- HUP9801219A2 HUP9801219A2 HU9801219A HUP9801219A HUP9801219A2 HU P9801219 A2 HUP9801219 A2 HU P9801219A2 HU 9801219 A HU9801219 A HU 9801219A HU P9801219 A HUP9801219 A HU P9801219A HU P9801219 A2 HUP9801219 A2 HU P9801219A2
- Authority
- HU
- Hungary
- Prior art keywords
- pipe powder
- general formula
- conditions
- powder
- pipe
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical class O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 title 1
- DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical compound N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
- 102000002852 Vasopressins Human genes 0.000 abstract 1
- 108010004977 Vasopressins Proteins 0.000 abstract 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000009103 reabsorption Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 229960003726 vasopressin Drugs 0.000 abstract 1
- 238000011514 vinification Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány az (I) általánős képletű vegyületekre, az azőkattartalmazó gyógyszerkészítményekre és az előállításűkra szőlgálóeljárásra vőnatkőzik. Az (I) általánős képletben a szűbsztitűensekfőntősabb jelentései a következők: Y jelentése -(CH2)-n, O, S, NH, -N(COCH3)- vagy -N-(1-3) szénatőmős)alkilcsőpőrt, ahől n értéke 0, 1, 2, A-B jelentése (a) vagy (b) általánős képletű csőpőrt, ahől m jelentése1 vagy 2, R1 jelentése hidrőgénatőm, halőgénatőm, hidrőxilcsőpőrt, nitrőcsőpőrtvagy aminőcsőpőrt, R2 jelentése hidrőgénatőm,halőgénatőm, hidrőxilcsőpőrt vagy 1-3szénatőmős alkilcsőpőrt, R3 jelentése (c) általánős képletű csőpőrt, és a Z-t tartalmazó gyűrű adőtt esetben szűbsztitűtált fenil-, tiőfén-,fűrán-, pirazől- vagy piridingyűrűt jelent. A találmány szerinti (I) általánős képletű vegyületek hasznősak őlyanállapőtők kezelésében, amelyeknél kívánatős a vazőpresszinszintekcsökkentése, ilyen állapőtők a vértőlűlással járó szívzavarők, atúlzőtt vízreabszőrpcióval járó vesepanaszők, a megnövekedett érbeliellenállással és kőszőrúér-szűkülettel járó állapőtők. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37316995A | 1995-01-17 | 1995-01-17 | |
US08/548,805 US5849735A (en) | 1995-01-17 | 1995-12-22 | Tricyclic benzazepine vasopressin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9801219A2 true HUP9801219A2 (hu) | 1998-10-28 |
HUP9801219A3 HUP9801219A3 (en) | 2000-07-28 |
Family
ID=27006077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9801219A HUP9801219A3 (en) | 1995-01-17 | 1996-01-16 | N-acylated tricyclic benzazepine and benzoxazepine derivatives, pharmaceutical compositions containing them, process for the preparation thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0804420A1 (hu) |
JP (1) | JPH10512865A (hu) |
CN (1) | CN1190391A (hu) |
AR (1) | AR002459A1 (hu) |
AU (1) | AU4904296A (hu) |
BR (1) | BR9606977A (hu) |
CA (1) | CA2210688A1 (hu) |
CZ (1) | CZ224597A3 (hu) |
EA (1) | EA000752B1 (hu) |
HU (1) | HUP9801219A3 (hu) |
IL (1) | IL116777A (hu) |
NZ (1) | NZ302881A (hu) |
TW (1) | TW449584B (hu) |
WO (1) | WO1996022282A1 (hu) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693635A (en) * | 1993-07-29 | 1997-12-02 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
WO1997047624A1 (en) * | 1996-06-13 | 1997-12-18 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
CN1162429C (zh) * | 1997-07-30 | 2004-08-18 | 惠氏公司 | 三环后叶加压素激动剂 |
US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
AR018818A1 (es) * | 1998-04-03 | 2001-12-12 | Yamano Masaki | Una composicion farmaceutica para la terapia de un edema. |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
WO2001017971A1 (fr) * | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Procede de preparation de derives 2,3-dihydroazepine |
US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US7053083B2 (en) | 2001-04-12 | 2006-05-30 | Wyeth | Cyclohexylphenyl vasopressin agonists |
US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
US7202239B2 (en) | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
BR0208823A (pt) | 2001-04-12 | 2004-03-09 | Wyeth Corp | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica |
US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US6977254B2 (en) | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7326700B2 (en) | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
EP2229364B1 (en) * | 2007-12-05 | 2015-02-25 | Janssen Pharmaceutica, N.V. | Dibenzoazepine and dibenzooxazepine trpa1 agonists |
JP5562865B2 (ja) | 2007-12-17 | 2014-07-30 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Trpv1のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター |
WO2010116176A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
EP3116509B1 (en) * | 2014-03-12 | 2022-06-22 | The Trustees of Columbia University in the City of New York | A new class of mu-opioid receptor agonists |
TWI698430B (zh) * | 2015-02-13 | 2020-07-11 | 南北兄弟藥業投資有限公司 | 三環化合物及其在藥物中的應用 |
CN110248944A (zh) | 2016-12-12 | 2019-09-17 | 悉尼大学 | 非肽催产素受体激动剂 |
CA3069720A1 (en) | 2017-07-11 | 2019-01-17 | Vertex Pharmaceuticals Incorporated | Carboxamides as modulators of sodium channels |
EP4146626A4 (en) | 2020-05-05 | 2024-05-29 | Nuvalent Inc | CHEMOTHERAPEUTIC AGENTS BASED ON HETEROAROMATIC MACROCYCLIC ETHERS |
WO2021226269A1 (en) | 2020-05-05 | 2021-11-11 | Nuvalent, Inc. | Heteroaromatic macrocyclic ether chemotherapeutic agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
KR0167349B1 (ko) * | 1989-10-20 | 1999-02-18 | 오스카 아끼히꼬 | 벤조헤테로 고리 화합물 |
GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
WO1995003305A1 (fr) * | 1993-07-21 | 1995-02-02 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de benzazepine de fusion et composition pharmaceutique renfermant ce derive |
US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
US5512563A (en) * | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
-
1996
- 1996-01-15 AR ARP960101027A patent/AR002459A1/es unknown
- 1996-01-16 HU HU9801219A patent/HUP9801219A3/hu unknown
- 1996-01-16 WO PCT/US1996/001051 patent/WO1996022282A1/en not_active Application Discontinuation
- 1996-01-16 IL IL11677796A patent/IL116777A/xx not_active IP Right Cessation
- 1996-01-16 JP JP8522448A patent/JPH10512865A/ja not_active Ceased
- 1996-01-16 EA EA199700116A patent/EA000752B1/ru not_active IP Right Cessation
- 1996-01-16 NZ NZ302881A patent/NZ302881A/xx unknown
- 1996-01-16 EP EP96905227A patent/EP0804420A1/en not_active Withdrawn
- 1996-01-16 BR BR9606977A patent/BR9606977A/pt not_active Application Discontinuation
- 1996-01-16 TW TW085100462A patent/TW449584B/zh not_active IP Right Cessation
- 1996-01-16 AU AU49042/96A patent/AU4904296A/en not_active Abandoned
- 1996-01-16 CZ CZ972245A patent/CZ224597A3/cs unknown
- 1996-01-16 CA CA002210688A patent/CA2210688A1/en not_active Abandoned
- 1996-01-16 CN CN96192568A patent/CN1190391A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0804420A1 (en) | 1997-11-05 |
AU4904296A (en) | 1996-08-07 |
TW449584B (en) | 2001-08-11 |
EA199700116A1 (ru) | 1997-12-30 |
AR002459A1 (es) | 1998-03-25 |
WO1996022282A1 (en) | 1996-07-25 |
CN1190391A (zh) | 1998-08-12 |
IL116777A (en) | 2000-11-21 |
CA2210688A1 (en) | 1996-07-25 |
HUP9801219A3 (en) | 2000-07-28 |
IL116777A0 (en) | 1996-05-14 |
NZ302881A (en) | 1999-03-29 |
JPH10512865A (ja) | 1998-12-08 |
CZ224597A3 (en) | 1997-12-17 |
BR9606977A (pt) | 1997-11-04 |
EA000752B1 (ru) | 2000-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9801219A2 (hu) | Triciklusos N-acilezett benzazepin és benzoxazepinszármazékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra | |
AU4306796A (en) | Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs | |
MY133406A (en) | 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament | |
HUP9802694A1 (hu) | Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0002112A2 (hu) | Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0203681A2 (hu) | Perifériális kannabinoid receptor specifikus agonistákat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
NZ520071A (en) | 4-aminopiperidine derivatives and their use as medicine | |
HUP9600448A2 (hu) | Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk | |
HUP0202810A2 (hu) | Szubsztituált 2-tio-3.5-diciano-4-aril-6-aminopiridinek és eljárás az előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HRP20041042A2 (en) | Novel substituted sulfamate anticonvulsant derivatives | |
FI913478A0 (fi) | Diazinderivat. | |
HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
RU94042922A (ru) | Новые соединения, способы их получения, фармацевтическая композиция | |
HUP0001498A2 (hu) | Farnezil-transzferáz-gátló 1,8-anellált imidazolil-kinolinon-származékok, intermedierjeik, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
NO944704L (no) | Tiazolidinderivater og farmasöytiske blandinger som inneholder disse | |
TW369535B (en) | A pyrazolopyridine compound and the process for preparing thereof | |
HUP0401009A2 (hu) | 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9802630A2 (hu) | Királis metil-fenil-oxazolidinonok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP9900851A2 (hu) | Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására | |
AP2001002191A0 (en) | 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives. | |
BG103426A (en) | Derivatives of substituted 4-biphenyl-4-hydroxy-oil acids as inhibitors of matrix metalloproteases | |
IL114833A (en) | Anthracyclinone derivatives for use as medicaments or for the manufacture of a medicament and pharmaceutical compositions comprising said derivatives for the treatment of amyloidosis, some such derivatives and processes for their preparation | |
BG103207A (en) | Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation | |
HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények |